Jonathan C. Fox, See Remarks at Eidos Therapeutics, Inc. (EIDX), sold 9,998 shares at $36.16 ($362K) on 2019-10-15, disclosed to the SEC on 2019-10-16.
Open-market sale of $362k EIDX by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.16 | 4,998 | $181K | 50.0% |
| 2 | $36.16 | 4,998 | $181K | 50.0% |
| 3 | $36.71 | 2 | $73 | 0.0% |
| Total | $36.16 avg | 9,998 | $362K | 100% |
| Filing → |
| EIDX | SELL | 2020-09-18 | $579K | — | Filing → |
| EIDX | SELL | 2020-09-16 | $369K | — | Filing → |
| EIDX | SELL | 2020-07-09 | $250K | — | Filing → |